cover
Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not quite as well — against new mutated strains of the virus circulating in that country and South Africa.

No comments yet, Let's kick-start a discussion.

Please Login or Register to Comment.